Provided by Tiger Fintech (Singapore) Pte. Ltd.

CITIUS ONCOLOGY INC

2.06
-0.1500-6.79%
Post-market: 2.100.0400+1.94%19:59 EDT
Volume:614.67K
Turnover:1.34M
Market Cap:161.44M
PE:-5.56
High:2.31
Open:2.25
Low:2.06
Close:2.21
Loading ...

Citius Oncology Closes $9 Million Offering of Shares, Warrants

MT Newswires Live
·
18 Jul

Citius Oncology Prices Public Offering at $1.32 a Share

MT Newswires Live
·
16 Jul

Citius Oncology Expands Lymphir Distribution With Cencora

MT Newswires Live
·
15 Jul

Citius Oncology Plans Stock Offering; Shares Down

MT Newswires Live
·
14 Jul

Citius Oncology On Track to Launch Lymphir in US in H2

MT Newswires Live
·
17 Jun

Citius Oncology expects commercial launch of Lymphir in second half of 2025

TIPRANKS
·
17 Jun

BRIEF-Citius Oncology Enters Into Distribution Services Agreement With Cardinal Health

Reuters
·
09 Jun

Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir

MT Newswires Live
·
09 Jun

Citius Oncology Cut to Hold From Buy by Maxim Group

Dow Jones
·
23 May

Maxim Downgrades Citius Oncology to Hold From Buy

MT Newswires Live
·
23 May

Citius Oncology downgraded to Hold from Buy at Maxim

TIPRANKS
·
23 May

BRIEF-Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update

Reuters
·
15 May

Citius Oncology Q2 EPS $(0.11) Misses $(0.09) Estimate

Benzinga
·
15 May

Citius Pharmaceuticals Reports Q2 2025 Financials: Net Loss Widens to $11.5 Million, EPS at ($1.27)

Reuters
·
15 May

Press Release: Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
15 May

BRIEF-Citius Oncology Inc - Receives Nasdaq Notice For Bid Price Non-Compliance - SEC Filing

Reuters
·
26 Apr

Wall Street Set to Open Lower Monday as Investors Gird for More Tariffs, Await Key Manufacturing Data

MT Newswires Live
·
31 Mar

Investors Brace for 'Liberation Day' as US Futures Trend Sharply Lower in Monday's Premarket

MT Newswires Live
·
31 Mar

Citius Oncology Q1 2025 GAAP EPS $(1.30) Misses $(0.06) Estimate

Benzinga
·
15 Feb

Press Release: Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
15 Feb